A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.
Clinical trial NCT00605722 · COMPLETED
Trial details
- NCT number
- NCT00605722
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2010-09-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.